!"#$%&'!"#$%$&'(')*&!

(+!),-.,/!0.!1.23.4.!+5/+!/,!3,6-.7+5!8,902.-:.!3,!/;<4.!3,:=.-3.,+>!-.=34.-!?=9@!@.-3;3,/2!72/,+>!/,-!+5.!>./=;5!?9=!.A;.22.,;.!/+!/22!<@.>!/=.!;=B;3/2!;9@@3+@.,+>!+9!>.=43,:!9B=!;B>+9@.=>!3,!75/=@/;.B<;/2>C!5./2+56?99->!/,-!7.=>9,/2!;/=.D!!#.>./=;5!/,-!7=9-B;<9,!+.;5,929:3.>!/=.!+5.!@/3,!?9;B>!9?!9B=!@3>>39,!/,-!+5.!0/E!0.!;=./+.!/! 4/2B.!-3F.=.,;. !?9=!9B=!7/=+,.=>D!(,-!0. 4.!:9+!()*+,-./0,12,3+/*4,)5,+67+*8+09+,+9!7=94.!3+D!

*G#,#:;;:"&,

#:<=;>"&=;,)&!'H$!?:;>"@',"A,:&B=&%,•! ),!C1DC!I/=29!J9;;/;;39!),4.=,3!1.:/,!7=9-B;3,:!+6-*/9-4,5*)(,(+E8980/F,7F/0-4,?9=!

75/=@/;3>+>!/,-!+5.!.@.=:3,:!)+/23/,!75/=@/;.B<;/2!3,-B>+=ED!K5.,!J3/:39!(21.=+9!L.22/!J.F/!M93,.-!/>!7/=+,.=!/,-!N/,/:3,:!L3=.;+9=C!+5.!O=@!1.;/@.!/!M93,+6>+9;8!;9@7/,EC!+=/-3,:!B,-.=!+5.!,/@.!9?!L9PD!),4.=,3!Q!L.22/!J.F/!%D7D(D!!

•! LB=3,:!+5.!A8G8+4C!J3/:39!(21.=+9R>!>9,!SB3:3!L.22/!J.F/!/--.-!+9!+5.!53>+9=3;/2!1B>3,.>>!/!0+H,7./*(/9+IJ9/F,E8K848)0,T),4.=,3!-.22/!J.F/!%D7D(DU!+9!@/,B?/;+B=.!/,-!@/=8.+!O,3>5.-!-9>/:.!?9=@>!?=9@!19+/,3;/2!-.=34/<4.>D!

•! ),!C1L1C!/!,.0!>3+.!?9=!+5.!7*)EI9J)0,)5,+6-*/9-4,/0E,7I*+,()F+9IF+4C!+9:.+5.=!03+5!/!7349+/2!=.>./=;5!/,-!-.4.297@.,+!;.,+=.C!0/>!>.+!B7!3,!%.P/2/C!,./=!N32/,D!!

•! ),!+5.!+/*F3,=8M.J+4C!+5.!19+/,3;/2!-.=34/<4.>!1B>3,.>>!0/>!=.9=:/,3>.-!/>!/!,.0!;9@7/,EC!:0E+0/,;N7N%N,,

•! ),!+5.!&80+J+4!:0E+0/C!/2=./-E!7=.>.,+!09=2-03-.!03+5!/!;9@@.=;3/2!/,-!;B2<4/<9,!,.+09=8C!97.,.-!,.0!7=9-B;<9,!72/,+>C!,9+/12E!3,!V=/,;.!/,-!),-3/C!/,-!/--3<9,/2!;9@@.=;3/2!1=/,;5.>D!

800  employees  5  interna<onal  branches  5  produc<on  sites  worldwide  sales  in  more  than  70  countries  more  than  120  primary  patents  

FACTS  &    

FIGURES  

'H$!)&L$&(!#%@U=>,

Dedicated areas

Purification

Plantations

GACP

Micropropagation

Pre-clinical

Screening ICH

HACCP

FDA cGMP

OECD

AIFA

Processes

Extraction

Clinical

Products

Biodiversity

Isolation

ANSM

QUALITY,SAFETY

& EFFICACY

RESEARCH

BOTANICALEXPERTISE SCALE UP

& INDUSTRIALPRODUCTION

:&B=&% ;,$:<<%@;,N9=.!+5/,!12,3+/*4,9?!53>+9=E!1/>.-!9,!?9B=!W7322/=>XD!

"2B>!;9,<,B9B>!/P.,<9,!+9!4I4-/80/V8F8-3!!/,-!+0K8*)0(+0-/F!3@7/;+D!

(,@=;=%@!?,J(%$L,!"#$%&',

$@"!=;;,@=;=%@!?Y!*=3:3,/2!/EK/09+E!3,-B>+=3/2!7=9-B;<9,!7*)9+44+4!/=.!!-.>3:,.-!/,-!.,:3,..=.-!?9=!09=8!9,!.A3><,:!9=!!,.0!@92.;B2.>D!!$@"BT!>,@=;=%@!?W,)-.,<O;/<9,!9?!0+H,/9JK+,7*80987F+4!-.=34.-!?=9@!72/,+>!!?9=!75/=@/;.B<;/2>C!5./2+56?99->!/,-!!7.=>9,/2!;/=.!1/>.-!9,Y!!•! =-.0)7./*(/9)F)M89/F!/,-!+78E+(8)F)M89/F!>+B-3.>D!!•! &+H,I4+4,9?!+=/-3<9,/2!/,-!/2=./-E!-.4.297.-!19+/,3;/2!7=9-B;+>D!!•! "=.6;23,3;/2!/,-!;23,3;/2!-.4.297@.,+D!

X">%&:!%<!%*G#I$%,

•! ),!/--3<9,!+9!+=/-3<9,/2!:/+5.=3,:!9?!032-!72/,+>C!),-.,/!5/>!.>+/123>5.-!/!H)*FEH8E+,0+-H)*Y,)5,7F/0-/J)04,+9!7=943-.!53:5!ZB/23+E!4.:.+/2!=/0!@/+.=3/2D!

!•! ),+.=,/<9,/22E!=.;9:,3>.-!V)-/089/F,+67+*-4,@9,3+9=!@9=.!+5/,![C\\\!

5.;+/=.>!9?!S))E,%M*89IF-I*/F,/0E,!)FF+9J)0,$*/9J9+4!T](I"U!;9@723/,+!72/,+/<9,>C!053;5!+9-/E!/;;9B,+!?9=!@9=.!+5/,!^\_!9?!+5.!4.:.+/2!=/0!@/+.=3/2!0.!B>.D!

!•! K.!7B=>B.!+5.!53:5.>+!19+/,3;/2!>+/,-/=->!03+5!(/68(I(,*+47+9-,5)*,-.+,

+0K8*)0(+0-,/0E,V8)E8K+*48-3D!!•! '9!/;53.4.!0.2263-.,<O.-!/,-!;9,>3>+.,+2E!53:56ZB/23+E!4.:.+/2!=/0!

@/+.=3/2C!0.!B>.!(89*)7*)7/M/J)0!/,-!+=/-3<9,/2!72/,+!1=..-3,:C!1B+!0+K+*,S#"D!

)&L$&(!$@"BT!>:"&,

•! (-4/,;.-C!53:52E!`.A312.!/,-!.,43=9,@.,+6?=3.,-2E!>+/+.69?6+5.6/=+!+.;5,929:E!3>!B>.-!+5=9B:59B+!+5.!),-.,/!@/,B?/;+B=3,:!;E;2.D!

•! ),-.,/ >!?/;323<.>!3,;9=79=/+.!4+7/*/-+,/I-.)*84+E,/*+/4,?9=!!5/,-23,:!75/=@/!/,-!?99-!:=/-.!,/+B=/2!-.=34/<4.>C!05.=.!!+5.!ZI/F8-3,;34-+(,+04I*+4,9)(7F8/09+,H8-.,9S#$,/0E,?/[/*E,,%0/F3484,/0E,!*3J9/F,!)0-*)F,$)80-4,\?%!!$],:B3-.23,.>D!

•! K3+5!@9=.!+5/,!C22,B#A4C!),-.,/ >!75/=@/;.B<;/2!7=9-B;+>!@..+!T;^AB%,/0E,=T,*+_I8*+(+0-4C!/,-!+09!7=9-B;<9,!>3+.>!/=.!/;;=.-3+.-!1E!a/7/,.>.!/B+59=3<.>D!

•! H./2+56?99-!7=.6@3A.-!7=.7/=/<9,D!

•! V.=@.,+/<9,!7=9-B;<9,!;/7/1323<.>D!

#%:&,$@"BT!>:"&,,=ZT:$#=&>;,('!*G#!%)'$%,

•! S*80E80M,/77/*/-I4,T5/@@.=6!/,-!8,3?.6:=3,-.=>U!b!72/,+!@/+.=3/2!:=3,-3,:D!

•! $+*9)F/-)*4!T>+/<;!/,-!-E,/@3;U!b!72/,+!@/+.=3/2!.A+=/;<9,D!

•! @+/9-)*4!b!=./;<9,C!;=E>+/223>/<9,C!;9,;.,+=/<9,D!

•! !)09+0-*/-)*4!T+53,6O2@!;9,;.,+=/+9=>U!b!>924.,+!.4/79=/<9,D!

•! <8_I8E^F8_I8E,+6-*/9-)*4,b!>.2.;<4.!.A+=/;<9,C!7B=3O;/<9,!7=9;.>>D!

•! !)FI(04,5)*,9.*)(/-)M*/7.3,b!;9,;.,+=/<9,C!7B=3O;/<9,C!3>92/<9,D!

•! !+0-*85IM+4`,aF-+*^7*+44,b!>923-623ZB3-!>.7/=/<9,D!

•! B*8+*4!T+=/E!-=3.=>C!-=3.=>!03+5!><==3,:C!@3;=90/4.U!b!-=E3,:D!

•! %-)(84+*4!b!/+9@3>/<9,D!

•! #8FF4,/0E,48+K+4,b!@3223,:!/,-!>3.43,:!9?!790-.=>D!

•! #86+*4!b!12.,-3,:!9?!790-.=>C!>+/,-/=-3>/<9,D!

$@"!=;;,B=;:S&,V*#!!?:S?^!"&>%:&#=&>,;'&>?=;:;!

•! $@"!=;;,B=b=<"$#=&>,R,;!%<:&S^T$,!%$%X:<:>:=;W,"=9;.>>!-.>3:,!?9=!H3:5!"9+.,;E!I9@79B,-!>E,+5.>3>D!#9B+.!97<@3c/<9,!T>+/<><;/2!L.>3:,!*?!$A7.=3@.,+U!/,-!>;/2.6B7D!"=.7/=/<9,!9?!>@/22!>;/2.!@/+.=3/2C!?=9@!:=/@>!+9!8329:=/@>D!;]N"!@/,B?/;+B=3,:!9?!(")>!?9=!;23,3;/2!+=3/2>D!!•! %&%<'>:!%<,R,$@=!<:&:!%<,;T$$"@>W,#.?.=.,;.!%+/,-/=-!Q!)@7B=3<.>!>E,+5.>3>!/,-!3>92/<9,D!(,/2E<;/2!N.+59-!L.4.297@.,+!Q!d/23-/<9,!/;;9=-3,:!+9!)IH!:B3-.23,.>D!%+/1323+E!>+B-3.>!B,-.=!)IH!;9,-3<9,>D!"92E@9=75!;5/=/;+.=3>/<9,D!!!>B,@+MIF/-)*3,;I77)*-N,,•! $@"BT!>:"&,;!%<=,!%$%X:<:>:=;W,V3=>+!7B=3O;/<9,!9?!;E+9+9A3;!(")>D!V3,/2!7B=3O;/<9,!/,-!-=E3,:!9?!;E+9+9A3;!(")>D!%.@36>E,+5.>3>!9?!;E+9+9A3;!(")>D!IE+9+9A3;!(")>!3,!/!-.-3;/+.-!-.7/=+@.,+!-90,>+=./@!?=9@!?.=@.,+/<9,D,%FF,7*)EI9J)0,4I8-+4,./K+,:0-+M*/-+E,$*)9+44,!)0-*)F,9/7/V8F8J+4N,,

)&L$&(!ZT%<:>'!

!•! V34.!72/,+>!09=83,:!B,-.=!9S#$4!/,-!/B+59=3>.-!?9=!

+5.!7=9-B;<9,!9?!%$:4D!!•! V9B=!72/,+>!09=83,:!B,-.=!?%!!$,/,-!/B+59=3>.-!?9=!

+5.!7=9-B;<9,!9?!5))E,80M*+E8+0-4D!!•! #9B<,.2E!3,>7.;+.-!1E!3,+.=,/<9,/2!=.:B2/+9=E!

/B+59=3<.>!238.!AB%C!%M+0[8/,:-/F8/0/,E+F,A/*(/9),\%:A%]!/,-!%M+09+,0/J)0/F+,E+,4c9I*8-c,EI,(cE89/(+0-,+-,E+4,7*)EI8-4,E+,4/0-c,\%&;#],?9=!S#$!;9@723/,;.!/>>.>>@.,+!/>!0.22!/>!1E!=.:B2/+9=E!/B+59=3<.>!?9=!5))E,4/5+-3,9)(7F8/09+D!

!•! IB>+9@.=>!>B;5!/>!3,+.=,/<9,/2!75/=@/;.B<;/2!

;9@7/,3.>!@/E!/2>9!;9,-B;+!+5.3=!90,!/B-3+>D!

;T;>%:&%X:<:>'!Q!!=&b:@"&#=&>,

),-.,/C!059>.!=/0!@/+.=3/2!3>!1E!-.O,3<9,!/!7/=+!9?!+5.!.,43=9,@.,+C!5/>!/!-..7!/,-!03-.6=/,:3,:!9)((8-(+0-,-),4I4-/80/V8F8-3,/0E,+0K8*)0(+0-/F,4/5+MI/*E80MD!!)+>!,.+09=8!9?!;B2<4/<9,>!>B7723.>!/2@9>+!+09!+53=->!9?!3+>!4.:.+/2!@/+.=3/2C!0532.!5/=4.><,:!9?!032-!72/,+>!3>!-9,.!03+5!>;=B7B29B>!;/=.!?9=!+5.!.,43=9,@.,+!/,-!/3@3,:!+9!*+47+9-,-.+,F)9/F,9)((I08J+4,+5/+!-.7.,-!9,!+59>.!19+/,3;/2!=.>9B=;.>!?9=!+5.3=!234.23599->D!!>.+,9)((8-(+0-,9)0J0I+4,-.*)IM.)I-,-.+,7*)9+4480M,/0E,7*)EI9J)0,7./4+4N,

ACTIVE  PHARMACEUTICAL    INGREDIENTS  Isolated  or  semisynthe<c  pure  products  and  extracts    are  produced  in  compliance  with  cGMPs  and  supported  by  CTD-­‐DMFs.    Among  our  main  products:  

PACLITAXEL    Taxus  media  Rehder  -­‐  Root,  Leaf  and  Twig  -­‐  ≥97.0%  ≤102.0%  by  HPLC  -­‐  An<cancer.    10-­‐DAB  III    Taxus  baccata  L.  -­‐  Twig  and  leaf  -­‐  ≥96.0%  by  HPLC  -­‐  Chemical  intermediate.    THIOCOLCHICOSIDE  Gloriosa  superba    L.  -­‐  Seed  -­‐  ≥98.0%  ≤102.0%  by  poten<ometry  -­‐  Muscle  relaxant.    COLCHICINE  Gloriosa  superba    L.  -­‐  Seed  -­‐  ≥97.0%  ≤102.0%  by  poten<ometry  -­‐  An<gout.    DOCETAXEL    Taxus  baccata    L.  -­‐  Twig  and  leaf  -­‐    ≥97.0%  ≤102.0%  by  HPLC  -­‐  An<cancer.    MYRTOCYAN®    Vaccinium  myr6llus    L.  -­‐  Fresh  frozen  fruit  -­‐  ≥32.4%  ≤39.6%  by  HPLC  -­‐  Capillarotropic.    ESCIN    Aesculus  hippocastanum    L.  -­‐  Seed  -­‐  ≥97.0%  ≤103.0%  by  poten<ometry  -­‐  An<oedema.    GINKGO  BILOBA  Ginkgo  biloba    L.  -­‐  Leaf  -­‐  ≥22.0%  ≤27.0%  of  flavonoids  by  HPLC,  ≥2.6%  ≤3.2%  of  bilobalide    by  HPLC,  ≥2.8%  ≤3.4%  of  ginkgolides  A,B,C  by  HPLC,  ≤5  ppm  of  ginkgolic  acids  by  HPLC  -­‐  Blood  circula<on  improver.  

HEALTH-­‐FOOD  INGREDIENTS  Indena  leverages  its  solid  pharmaceu<cal  background    for  the  health-­‐food  field,  developing  biologically  ac<ve    ingredients  for  supplements,  func<onal,  medical  and  baby  food  products  for  more  than  40  years.  These  include:  

MIRTOSELECT®    Vaccinium  myr6llus    L.  -­‐  Fresh  frozen  fruit  -­‐  ≥36.0%  of  anthocyanins  by  HPLC  -­‐  ≥25.0%  anthocyanins  as  anthocyanidins  by  spectrophotometry  -­‐  Eye  health,  Circulatory  health,  An<oxidant  ac<vity.    LEUCOSELECT®    Vi6s  vinifera    L.  -­‐  Seed  -­‐    ≥95.0%  ≤105.0%  of  proanthocyanidins  by  GPC,  ≥13.0%  ≤19.0%  of  catechin  and  epicatechin  by  HPLC  -­‐  An<oxidant  ac<vity,  Circulatory  health.    GREENSELECT®    Camellia  sinensis    (L.)  O.  Kuntze  -­‐  Young  leaf  -­‐  ≥60.0%  of  total  polyphenols,  ≥40.0%  of  (-­‐)-­‐epigallocatechin-­‐3-­‐O-­‐gallate,  ≤0.1%  of  caffeine  by  HPLC  -­‐  An<oxidant  ac<vity.    OPEXTAN®  Olea  europaea  L.  -­‐  Fruit  -­‐  ≥10.0%  of  total  polyphenols  by  spectrophotometry,  ≥2.0%  ≤3.5%  of  verbascoside  by  HPLC,  ≥4.5%  of  hydroxytyrosol  and  its  deriva<ves  by  HPLC  -­‐  An<oxidant  ac<vity,  Healthy  skin,  Healthy  cardiovascular  func<on.    BEANBLOCK®  Phaseolus  vulgaris    L.  -­‐  Common  bean  -­‐  ≥6.0%  as  alpha  amylase  inhibitor  by  HPLC  1,100  U/mg  of  alpha  amylase  inhibi<ng  ac<vity,  30,000  HAU/g  of  hemagglu<na<ng  ac<vity  by  spectroph./enzym.  -­‐  Appe<te  regulator,  Healthy  blood  sugar  metabolism.  

PERSONAL  CARE  INGREDIENTS  Indena  develops  func<onal  ingredients  with  a  wide  range  of  applica<ons  for  “high”  skin  &  hair  care  products,  including:  

ESCIN  Aesculus  hippocastanum    L.  -­‐  Seed  -­‐-­‐  ≥97.0%  ≤103.0%    by  poten<ometry  -­‐  Capillarotropic.    CENTELLA  ASIATICA  TRITERPENES  Centella  asia6ca    (L.)  Urban  -­‐  Leaf  -­‐  ≥36.0%  ≤44.0%  of  asia<coside,  ≥56.0%  ≤64.0%  of  genins  as  sum  of  asia<c  acid  and  madecassic  acid  by  HPLC  -­‐  An<-­‐wrinkles,  Stretchmarks  improver.    RUSCOGENINS    Ruscus  aculeatus    L.  -­‐  Rhizome  and  root  -­‐  ≥92.0%  ≤103.0%  of  ruscogenins,  ≥60.0%  ≤80%  of    neoruscogenin,  ≥20.0%                ≤40.0%  of  ruscogenin  by  HPLC    An<cellulite,  Vasoprotectant.    

CURBILENE®    Cucurbita  pepo    L.  -­‐  Naked  seed  -­‐  ≥85.0%  of  faPy  acids  by  GC  -­‐  Skin  maqng  agent.    ZANTHALENE®    Zanthoxylum  bungeanum    Maxim.  -­‐  Pericarp    -­‐    ≥4.4%  ≤6.4%  of  alkylamides  by  HPLC  -­‐  An<-­‐itching,  Skin  sensi<vity  modulator.    

XILOGEL®    Tamarindus  indica    L.  -­‐  Seed  -­‐  ≥85.0%  by  HPLC  -­‐  Moisturizer,  Skin  restructurant,  An<-­‐wrinkles.    CENTEVITA®    Centella  asia<ca    (L.)  Urban  -­‐  Leaf  -­‐  ≥45.0%  of  the  sum  of  asia<coside,  madecassoside,  asia<c  and  madecassic  acids  by  HPLC  -­‐  Collagen  restructurant  and  an<-­‐glyca<on  agent.    

BOSEXIL®    Boswellia  serrata    Roxb.  ex  Colebr.  -­‐  Resin  -­‐  ≥25.0%  boswellic  acids  by  HPLC  -­‐  Soothing,  An<-­‐photo  ageing.  

PHYTOSOME®  MORE  BIOAVAILABLE  Indena  has  developed  a  proprietary    technology  to  op<mise  the  bioavailability  of  selected  phytochemicals.      Products  include:  

CASPEROME®  Boswellia  serrata  Roxb.  ex  Colebr.  -­‐  Resin  -­‐  ≥25.0%  boswellic  acids  by  HPLC  -­‐  For  healthy  inflammatory  response.    MERIVA®    Curcuma  longa  L.  -­‐  Rhizome  -­‐  ≥18.0%  ≤22.0%  of  curcuminoids  by  HPLC  -­‐  Joint  health,  For  healthy  inflammatory  response.    SILIPHOS®  Silybum  marianum  L.  Gaertn.  -­‐  Fruit  -­‐  ≥29.7%  ≤36.3%  of  silybin  by  HPLC  -­‐  Healthy  liver.    GREENSELECT®  Camellia  sinensis    (L.)  O.  Kuntze  -­‐  Young  leaf  -­‐  ≥19.0%  ≤25.0%  of  polyphenols  expressed  as  (-­‐)-­‐epigallocatechin-­‐3-­‐O-­‐gallate,  ≥13.0%  of  (-­‐)-­‐epigallocatechin-­‐3-­‐O-­‐gallate,  ≤0.1%  of  caffeine  by  HPLC  -­‐  An<oxidant,  Weight  loss  agent.    LEUCOSELECT®  Vi6s  vinifera    L.  -­‐  Seed  -­‐  ≥25.0%  ≤30.0%  of  proanthocyanidins  by  GPC  -­‐  Cardiovascular  protectant,  UV  protectant,  An<oxidant.    GINKGOSELECT®  Ginkgo  biloba    L.  -­‐  Leaf  -­‐  ≥7.0%  of  ginkgoflavonglucosides,  ≥2.0%  of  ginkgoterpenes,  ≥0.8%  of  bilobalide,  ≥0.8%  of  ginkgolides  by  HPLC  ≤5  ppm  of  total  ginkgolic  acids  by  HPLC  -­‐  Cogni<on  and  circula<on  improver,  An<oxidant,  Vasokine<c.  

V**L%,R,VS(d*G#%!),-.,/!2.4.=/:.>!3+>!>923-!19+/,3;/2!1/;8:=9B,-!03+5!/!=/,:.!9?!?99-!Q!`/49B=!3,:=.-3.,+>!?9=!+5.!75/=@/;.B<;/2!/,-!?99-!3,-B>+=3.>C!3,;2B-3,:Y!

S@==&,>=%,="'(//*"&%*4(4%*%&TSDU!*D!nB,+c.!6!o9B,:!2./?!6!egmD\_!9?!+9+/2!792E75.,92>!1E!>7.;+=9759+9@.+=EC!e[mD\_!9?!+9+/2!;/+.;53,!.A7=.>>.-!/>!.73:/229;/+.;53,6[6*6:/22/+.C!eimD\_!9?!.73:/229;/+.;53,6[6*6:/22/+.!6!'9,3;C!(,<9A3-/,+D!!

<:&B=&,>@==,!*/*"&,01)"-"!!N322D!p'323/!72/+E75E229>!%;97D!6!V290.=!6!e\Dm_!9?!`/49,93->!1E!H"SI!6!%7/>@92E<;C!L3B=.<;D!!ZT%;;=<=!>,^,ZT%;;:%,?*,1"%'"&(#,(/%"!T%0DU!"2/,;5D!TE$"%%*"&"'"1"&SDU!6!K99-!6!em[D\_!hmgD\_!/>!/!>B@!9?!ZB/>>3,!/,-!,.9ZB/>>3,!1E!H"SI!6!V2/49B=3,:C!J3P.=D!!

b%&:<<%! !3"4*//"&2/"4*<0/*"&TJD!LD!a/;8>9,U!6!I/7>B2.!6!emD\_!9?!4/,3223,!1E!H"SI!6!V2/49B=3,:C!%0..+D!!!:&!?"&%!!=*4,804"!>77D!6!J/=8!6!eifD\_!hjiD\_!9?!+9+/2!/28/293->!6!V2/49B=3,:C!J3P.=D!!

S<'!%#:<,!"#$"T&B,&,,./5,5118*F"&:/"+1"!!SD6!#99+!6!efDm_!hi\Dm_!9?!+=3+.=7.,3;!:2B;9>3-.>!/>!@9,9/@@9,3B@!:2E;E==53c/+.!6!V2/49B=3,:C!%0..+D!!<:!"@:!=!!./5,5118*F"&:/"+1"!SD6!#99+!6!emD\_!h^Dj_!9?!:2E;E==53c3;!/;3-!1E!H"SI!6!V2/49B=3,:C!%0..+D!

$<%&>;,V*#,$<%&>;r!),-.,/!!I4-)(,B+K+F)7(+0-,>.=43;.!?9=!+5.!!.A+=/;<9,C!3>92/<9,!/,-!7B=3O;/<9,!9?!,/+B=/2!!-.=34/<4.>C!3,;2B-3,:!/!?B22!=/,:.!9?!@/,B?/;+B=3,:!;/7/1323<.>!?9=!?99-!/,-!75/=@/!:=/-.!3,:=.-3.,+>!9,!/!03-.!=/,:.!9?!>;/2.>D!!'5.!;9@13,/<9,!9?!),-.,/R>!.A7.=<>.!/,-!4-/-+^)5^-.+^/*-,5/98F8J+4!-.234.=>!7=9-B;+>!/,-!7=9;.>>.>!?=9@!4(/FF,49/F+,-),F/*M+,9)((+*98/F,(/0I5/9-I*80M!97.=/<9,>D!!K.!>5/=.!03+5!9B=!7/=+,.=>Y!!•! *B=!+67+*J4+!3,!/:=9,9@EC!75E+9;5.@3>+=EC!/,-!

.+5,975/=@/;929:ED!!•! *B=!S%!$!;9@723/,+!7F/0-/J)04!,.+09=8D!!•! *B=!7*)EI9J)0,9/7/V8F8J+4,/+!2/1C!78F)-!/,-!3,-B>+=3/2!

>;/2.D!!•! *B=!8,906590!3,!+5.!5)*(IF/J)0!9?!19+/,3;/2!3,:=.-3.,+>D!

B:;;=#:&%>:&S!n&*KS$L]$!!*&!#=B:!:&%<,$<%&>;,

),-.,/!/;+>!+9!5)4-+*,80-+*+4-,80,(+E8980/F,7F/0-4,/0E,,0/-I*/F,7*)EI9-4Y!!!!•! 1E!?9B,-3,:!A8-)-+*/78/C!/!a9B=,/2!7B123>5.-!>3,;.!ifjl!/,-!

+9-/E!=.;9:,3>.-!/>!/!7=.@3.=!>9B=;.!?9=!=.>./=;5!9,!@.-3;3,/2!72/,+>!Tj\ij!)@7/;+!V/;+9=Y!jDj[iC!;B==.,+2E!-3>+=31B+.-!1E!$2>.43.=UD!

!•! 1E!7B123>53,:!()0)M*/7.4!/,-!V))Y4!9,!@.-3;3,/2!72/,+>D!!•! 1E!>79,>9=3,:!#/4-+*4!/,-!>7.;3/23>+!>;5992>!3,!75E+9+5.=/7ED!!•! 1E!9F.=3,:!>;592/=>537!:=/,+>!+9!3)I0M,*+4+/*9.+*4D!

>?=,:&B=&%,$@"BT!>:"&,;:>=;,

),-.,/!%D7D(D!s!N32/,!s!)+/2E!

),-.,/!%D7D(D!s!%.P/2/!TN)U!s!)+/2E!

),-.,/!%D(D%D!s!'9B=>!s!V=/,;.!

J.=,.P!%D=D2D!s!"/2.>+=9!T"dU!s!)+/2E!

),-.,/!),-3/!"4+6!S+-D!s!J/,:/29=.!s!),-3/!

'H$!)&L$&(!"@S%&:;%>:"&,